New FDA Warning Added to Popular Weight Loss Drugs
Nov. 6, 2024 – The FDA has updated the labels for all GLP-1 weight loss drugs with a warning about pulmonary aspiration during general anesthesia or deep sedation. The affected drugs are liraglutide (Saxenda, Victoza), semaglutide (Ozempic, Rybelsus, Wegovy), and tirzepatide (Mounjaro, Zepbound).
Are Diabetes Drugs Really Safe (& Reliable) for Weight Loss?
There’s been lots of attention on type 2 diabetes drugs recently, especially since they might also be able to support weight loss. Whether you have type 2 diabetes or obesity, you may have heard about medications like Ozempic® that can help manage blood sugar levels and weight.
Weight loss can be a challenge, even for those who eat healthily and exercise regularly. But injectable type 2 diabetes ...
Real weight-loss medication pens should have unique identification codes ... "It's important that patients are aware that Novo Nordisk is the only company in the U.S. with FDA-approved ...
People on MSN3d
Mom Overdosed on Weight Loss Drug She Got on Instagram, Recalls 'Throwing Up Blood': 'Thought I Was Going to Die'Leigh-Anne Lagden, 26, opened up about being hospitalized after accidentally overdosing on knockoff weight loss injections ...
News Nation on MSN1d
Ozempic can lead to muscle mass loss: StudyRecent studies have found that Ozempic could lead to more muscle mass loss than traditional weight loss methods.
Feb. 22, 2024 When the semaglutide medication Wegovy first hit the market in 2021, it became the first weight-loss ...
The "Today" host underwent gastric bypass surgery in 2002 to help him lose weight.
Losing weight on GLP-1 drugs like Ozempic isn't guaranteed. Experts reveal how to tell if yours isn't working and the next steps you should take to reach your weight loss goals.
Novo Nordisk addresses safety concerns surrounding compounded versions of its weight-loss and diabetes drugs, including ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback